A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer
The purpose of this study is to find out how effective and safe glipizide is for lowering blood sugar in people with pancreatic cancer.
Pancreatic Cancer|Pancreatic Carcinoma|Pancreatic Ductal Adenocarcinoma|Pancreatic Cancer Metastatic|Metastatic Pancreatic Cancer|Metastatic Pancreatic Ductal Adenocarcinoma
DRUG: Glipizide
Change in mean interstitial glucose level for Cohort 1 participants before and after initiation of glipizide, The mean value measured over a 48-h period before initiation of glipizide will be compared with the mean value measured over a 48-h period after glipizide initiation for participants in Cohort 1, 48 hours after glipizide initiation
The purpose of this study is to find out how effective and safe glipizide is for lowering blood sugar in people with pancreatic cancer.